Pharmaceutical Industry discussion, review, analysis, news and information. |
« Novartis AG Will Launch Anti-Malaria Project | Main | ProEthic Pharmaceuticals Initiates Phase III Trial for Migraine Drug »
|
May27
|
 "As part of the transition, Trinity will transfer production of the diagnostic tests and instruments from bioMérieux's facilities in North Carolina to Dublin and from St Louis to Jamestown, New York respectively," the company said in a statement. The firm also said in the press release that the company will focus on infectious diseases, cancer and cardiovascular diseases instead. The deal is expected to close before June 30. Source: Biomerieux |
TrackBack URL for this entry:
« Novartis AG Will Launch Anti-Malaria Project | Main | ProEthic Pharmaceuticals Initiates Phase III Trial for Migraine Drug »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview